Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock
Portfolio Pulse from Avi Kapoor
Jim Cramer, on CNBC's 'Mad Money Lightning Round,' expressed his views on several stocks. He recommended avoiding Surgery Partners, Inc. (SGRY) due to the industry's volatility, despite the company reaffirming its 2023 EBITDA and revenue guidance. He was cautious about CRISPR Therapeutics AG (CRSP) because of their losses, even though the FDA approved their gene-edited cell therapy. Cramer has consistently disliked Vodafone Group (VOD) for 20 years, despite their new alliance with Microsoft. He was uncertain about DigitalOcean Holdings, Inc. (DOCN) due to its stock performance not reflecting its good business, and they have appointed a new CEO. Cramer believes it's not too late to buy Energy Transfer LP (ET), which recently increased its cash distribution. Lastly, he was neutral on MP Materials Corp. (MP), which experienced a slight stock decline.
January 31, 2024 | 12:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cramer believes it's not too late to buy Energy Transfer, which has announced an increase in quarterly cash distribution.
Cramer's positive recommendation and the increase in cash distribution could lead to a short-term positive impact on ET's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
Cramer was cautious about CRISPR Therapeutics due to their losses, despite FDA approval for their gene-edited cell therapy.
While FDA approval is positive, Cramer's focus on the company's losses could temper investor enthusiasm, leading to a neutral short-term impact.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Cramer is unsure about DigitalOcean due to its stock performance not aligning with its good business, and the company has a new CEO.
Cramer's uncertainty about the stock's poor performance despite positive business indicators could lead to a neutral short-term impact.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
NEUTRAL IMPACT
Cramer is neutral on MP Materials, which saw a slight decline in stock price, stating it 'never lifts' but he is not against it.
Cramer's neutral stance, combined with the stock's minor decline, suggests a neutral short-term impact on MP's stock price.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 50
NEGATIVE IMPACT
Jim Cramer recommended avoiding Surgery Partners due to industry volatility, despite reaffirming its financial guidance for 2023.
Cramer's negative stance on the industry's instability could influence investor sentiment, potentially leading to a short-term negative impact on SGRY's stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Cramer has not liked Vodafone for 20 years, a sentiment that persists despite their new strategic alliance with Microsoft.
Cramer's long-standing negative view, despite the Microsoft alliance, could influence investors to maintain a bearish outlook on VOD.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60